Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to -$1.8 million.

  • Rockwell Medical's Net Income towards Common Stockholders fell 20901.44% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year decrease of 31210.37%. This contributed to the annual value of -$554000.0 for FY2024, which is 9367.58% up from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Net Income towards Common Stockholders is -$1.8 million, which was down 20901.44% from -$1.6 million recorded in Q2 2025.
  • Rockwell Medical's 5-year Net Income towards Common Stockholders high stood at $1.7 million for Q3 2024, and its period low was -$8.9 million during Q4 2021.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$2.1 million (2023), whereas its average is -$3.5 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first surged by 17954.11% in 2024, then crashed by 63287.67% in 2025.
  • Rockwell Medical's Net Income towards Common Stockholders (Quarter) stood at -$8.9 million in 2021, then surged by 73.59% to -$2.4 million in 2022, then soared by 31.71% to -$1.6 million in 2023, then skyrocketed by 51.7% to -$779000.0 in 2024, then crashed by 132.86% to -$1.8 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$1.8 million for Q3 2025, versus -$1.6 million for Q2 2025 and -$1.6 million for Q1 2025.